Genetic Signatures advised it is has appointed Mr. Karl Pechmann as Chief Financial and Operating Officer (CFO & COO) and Company Secretary effective 26 June 2023. Mr. Pechmann is a senior executive focused on driving organisational growth and has extensive experience in ASX-listed companies and multi-national organisations, including OncoSil Medical Limited, Kyckr Limited and Immutep Limited. In these roles, Mr. Pechmann has been responsible for numerous operational areas including finance, investor relations, treasury, operations and information technology.

Mr. Pechmann is a qualified Chartered Accountant and Chartered Secretary. The appointment of Mr. Pechmann follows the resignation of Mr. Peter Manley on 27 March 2023, and will succeed the current Interim CFO and Company Secretary, Mr. Anthony Rule.